Tradestie Institutional Equity Comparison Engine

BHST vs JBSS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

JBSS Overall Edge

JBSS Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to John B. Sanfilippo & SON (JBSS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BHST trades at N/M Forward P/E with -18.0% operating margin (+3.8% YoY revenue) versus JBSS at 10.1x Forward P/E and 6.7% operating margin (-3.5% YoY). In options structure, BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against JBSS sits in BREAKDOWN (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner JBSS
BHST N/M vs JBSS 10.1x Fwd P/E
Growth & Margin Winner JBSS
Op Margin -18.0% vs 6.7% ยท YoY +3.8% vs -3.5%
Momentum & Technical Winner JBSS
1Y -79.4% vs -11.4% ยท 52W Pos 6% vs 25%
Options & Structure Winner JBSS
UNCLASSIFIED (N/A IV) vs BREAKDOWN (18th %ile IV)
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
1M Return -22.62%
1Y Return -79.4%
Forward P/E N/M
Unified AI Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
JBSS NASDAQ
John B. Sanfilippo & SON
Sugar & Confectionery Products
$61.07
+0.49% 1D
Market Cap $710.6M
1M Return -10.55%
1Y Return -11.36%
Forward P/E 10.1x
Unified AI Score
47.3 / 100 HOLD
Tech 53.0 Fund 55.0 Flow 62.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BHST -79.4% JBSS -11.36% Spread: +68.04 pp (JBSS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BHST Revenue JBSS Revenue BHST Op. Margin JBSS Op. Margin Margin Edge
FY2019 N/A $880M N/A 6.7% JBSS
FY2020 N/A $880M N/A 8.9% JBSS
FY2021 N/A $860M N/A 9.9% JBSS
FY2022 N/A $960M N/A 9.1% JBSS
FY2023 $10M $1.00B -78.6% 9.0% JBSS
FY2024 $30M $1.07B -27.7% 8.0% JBSS
FY2025 $30M $1.11B -16.2% 7.7% JBSS
FY2026 N/A $1.18B N/A 7.6% JBSS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BHST (2) vs JBSS (8)
Institutional Metric BHST JBSS Criterion Row Winner
Market Capitalization Scale $29.9M $710.6M Larger Scale JBSS
Trailing P/E Ratio Valuation N/M 12.7x Lower Multiple JBSS
Forward P/E Ratio Valuation N/M 10.1x Lower Multiple JBSS
Revenue Growth (YoY) Growth +3.8% -3.5% Higher Growth BHST
Operating Margin (TTM) Profitability -18.0% 6.7% Higher Margin JBSS
Net Profit Margin Profitability -31.2% 4.8% Higher Margin JBSS
Return on Equity (ROE) Capital Efficiency -142.5% 15.4% Higher ROE JBSS
52-Week Range Position Momentum 6% ($1โ€“$7) 25% ($51โ€“$92) Stronger Trend JBSS
Beta / 30D Volatility Risk Regime 0.25ฮฒ ยท 86% Vol 0.21ฮฒ ยท 62% Vol Lower Realized Risk JBSS
Unified Institutional Score Composite Signal 58.2 / 100 (HOLD) 47.3 / 100 (HOLD) Higher Composite BHST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BHST vs JBSS Buy Guide
BHST UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BHST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
JBSS BREAKDOWN
99d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live JBSS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BHST nor JBSS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.